Recent advancements in diabetes therapy have introduced a new class of drugs known as GLP-1 receptor agonists. These medications, which mimic the effects of a naturally occurring hormone called glucagon-like peptide-1 (GLP-1), offer a innovative approach to controlling blood sugar levels in individuals with diabetes. GLP-1 receptor agonists work by

Emerging in the landscape of weight management therapy, retatrutide represents a unique method. Beyond many available medications, retatrutide works as a double agonist, simultaneously affecting both glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic substance (GIP) sensors. This dual stimulation promotes several advantageous effe